Drug Type Autologous CAR-T |
Synonyms LB 2101, LB-2101, LB2101 |
Target |
Mechanism GPC3 modulators(Glypican-3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Hepatocellular Carcinoma | Phase 1 | CN | 19 May 2022 | |
Liver Cancer | Preclinical | - | - | |
Lung Cancer | Preclinical | - | - |